3
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Detection of SARS-CoV-2 B.1.1.529 (Omicron) variant by SYBR Green-based RT-qPCR

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The coronavirus disease 2019 (COVID-19) pandemic is unceasingly spreading across the globe, and recently a highly transmissible Omicron SARS-CoV-2 variant (B.1.1.529) has been discovered in South Africa and Botswana. Rapid identification of this variant is essential for pandemic assessment and containment. However, variant identification is mainly being performed using expensive and time-consuming genomic sequencing. In this study, we propose an alternative RT-qPCR approach for the detection of the Omicron BA.1 variant using a low-cost and rapid SYBR Green method. We have designed specific primers to confirm the deletion mutations in the spike (S Δ143-145) and the nucleocapsid (N Δ31-33) which are characteristics of this variant. For the evaluation, we used 120 clinical samples from patients with PCR-confirmed SARS-CoV-2 infections, and displaying an S-gene target failure (SGTF) when using TaqPath COVID-19 kit (Thermo Fisher Scientific, Waltham, USA) that included the ORF1ab, S, and N gene targets. Our results showed that all the 120 samples harbored S Δ143-145 and N Δ31-33, which was further confirmed by whole-genome sequencing of 10 samples, thereby validating our SYBR Green-based protocol. This protocol can be easily implemented to rapidly confirm the diagnosis of the Omicron BA.1 variant in COVID-19 patients and prevent its spread among populations, especially in countries with high prevalence of SGTF profile.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

          Background The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur. Aim We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available. Methods Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology. Results The workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive – Global (EVAg), a European Union infrastructure project. Conclusion The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein

            Continued uncontrolled transmission of SARS-CoV-2 in many parts of the world is creating conditions for substantial evolutionary changes to the virus1,2. Here we describe a newly arisen lineage of SARS-CoV-2 (designated 501Y.V2; also known as B.1.351 or 20H) that is defined by eight mutations in the spike protein, including three substitutions (K417N, E484K and N501Y) at residues in its receptor-binding domain that may have functional importance3-5. This lineage was identified in South Africa after the first wave of the epidemic in a severely affected metropolitan area (Nelson Mandela Bay) that is located on the coast of the Eastern Cape province. This lineage spread rapidly, and became dominant in Eastern Cape, Western Cape and KwaZulu-Natal provinces within weeks. Although the full import of the mutations is yet to be determined, the genomic data-which show rapid expansion and displacement of other lineages in several regions-suggest that this lineage is associated with a selection advantage that most plausibly results from increased transmissibility or immune escape6-8.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

              Despite an extensive network of primary care availability, Brazil has suffered profoundly during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Using daily data from state health offices, Castro et al. analyzed the pattern of spread of COVID-19 cases and deaths in the country from February to October 2020. Clusters of deaths before cases became apparent indicated unmitigated spread. SARS-CoV-2 circulated undetected in Brazil for more than a month as it spread north from S o Paulo. In Manaus, transmission reached unprecedented levels after a momentary respite in mid-2020. Faria et al. tracked the evolution of a new, more aggressive lineage called P.1, which has 17 mutations, including three (K417T, E484K, and N501Y) in the spike protein. After a period of accelerated evolution, this variant emerged in Brazil during November 2020. Coupled with the emergence of P.1, disease spread was accelerated by stark local inequalities and political upheaval, which compromised a prompt federal response. Science , abh1558 and abh2644, this issue p. [Related article:] 821 and p. 815 A variant lineage of SARS-CoV-2 associated with rapid transmission in Manaus, Brazil, evolved in November 2020 with immune escape characteristics. Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Manaus, Brazil, resurged in late 2020 despite previously high levels of infection. Genome sequencing of viruses sampled in Manaus between November 2020 and January 2021 revealed the emergence and circulation of a novel SARS-CoV-2 variant of concern. Lineage P.1 acquired 17 mutations, including a trio in the spike protein (K417T, E484K, and N501Y) associated with increased binding to the human ACE2 (angiotensin-converting enzyme 2) receptor. Molecular clock analysis shows that P.1 emergence occurred around mid-November 2020 and was preceded by a period of faster molecular evolution. Using a two-category dynamical model that integrates genomic and mortality data, we estimate that P.1 may be 1.7- to 2.4-fold more transmissible and that previous (non-P.1) infection provides 54 to 79% of the protection against infection with P.1 that it provides against non-P.1 lineages. Enhanced global genomic surveillance of variants of concern, which may exhibit increased transmissibility and/or immune evasion, is critical to accelerate pandemic responsiveness.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: InvestigationRole: MethodologyRole: Project administrationRole: SupervisionRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: MethodologyRole: Writing - original draftRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: MethodologyRole: Project administrationRole: Writing - original draftRole: Writing - review & editing
                Role: Funding acquisitionRole: SupervisionRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: MethodologyRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Journal
                Biol Methods Protoc
                Biol Methods Protoc
                biomethods
                Biology Methods & Protocols
                Oxford University Press
                2396-8923
                2024
                27 April 2024
                27 April 2024
                : 9
                : 1
                : bpae020
                Affiliations
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of science I, Lebanese University , Rafik Hariri Campus, Hadat. Lebanon
                Author notes
                Correspondence address. Laboratory of Molecular Biology and Cancer Immunology (COVID-19 Unit), Faculty of Science I, Lebanese University, Rafik Hariri Campus, Hadat. Lebanon (B.B and K.H). Tel: 009613675642; E-mail: bassam.badran@ 123456ul.edu.lb (B.B.). Tel: 0096170258296; E-mail: kassem.hamze@ 123456ul.edu.lb (K.H.).
                Author information
                https://orcid.org/0000-0001-6740-4817
                Article
                bpae020
                10.1093/biomethods/bpae020
                11055497
                38680163
                20e5e952-95b8-442e-83b4-4cfae1eff5ea
                © The Author(s) 2024. Published by Oxford University Press.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 10 December 2023
                : 23 February 2024
                : 18 March 2024
                : 27 April 2024
                Page count
                Pages: 7
                Funding
                Funded by: Lebanese University, DOI 10.13039/501100004113;
                Categories
                Methods Article
                BiologyMethodsandProtocols/12
                AcademicSubjects/SCI00960

                variants of concern,b.1.1.529,sars-cov2 rt-pcr,sgtf
                variants of concern, b.1.1.529, sars-cov2 rt-pcr, sgtf

                Comments

                Comment on this article